Depression, stress, and anxiety in pregnant women that occurred as a result of the COVID-29 pandemic may have an impact on fetal brain development.
Ketamine treatment leads to an increase in IGF-1, which, in turn, produces an antidepressant effect.
Researchers explore the effect psychedelics have on the brain and how they are effective at treating depression.
Negative metacognitions and rumination can exacerbate symptoms of depression, researchers say.
A preclinical drug that inhibits the kinase enzyme Cdk5 may have the potential to treat depression, brain injuries, and disorders associated with cognitive impairment.
Adventurous play, especially when conducted outdoors, was associated with reduced anxiety and depression in children.
A new study reveals the mechanisms behind repetitive transcranial magnetic stimulation's effect on the brain in the treatment of depression.
Researchers report a significant increase in deaths related to alcohol use disorder during the COVID-19 pandemic. The steepest increase in mortality was seen in the 25-44 age group.
Using psychiatric medications to treat mental health disorders in children and adolescents does not increase the risk of developing substance use disorders later in life. In fact, pharmacological interventions reduce the risk of developing SUD for those with MDD, ADHD, and psychotic disorders.
Statins reduced negative emotional bias in people with depression. The findings suggest statins may provide protection against depression.
Researchers have identified six predictors that may help determine the correct amount of lithium to treat a patient with bipolar disorder.
Mouse study reveals how depression and chronic stress can have an impact on cholesterol-lowering medications and influence the risk of heart disease.
